Techno Medical PCL (BKK:TM) ROCE %: 9.19% (As of Mar. 2026)


BKK:TM Techno Medical PCL BKK:TM
74 GF Score
Price ฿0.94
GF Value ฿1.20
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Techno Medical PCL ROCE %?

Techno Medical PCL BKK:TM +1.08% 74 ROCE % is 9.19% as of Mar. 2026. GuruFocus rates BKK:TM with a GF Score™ of 74/100 and a GF Value™ of ฿1.20 (Modestly Undervalued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Techno Medical PCL's annualized ROCE % for the quarter that ended in Mar. 2026 was 9.19%.

Techno Medical PCL  (BKK:TM) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Techno Medical PCL ROCE % Related Terms

Techno Medical PCL ROCE % Historical Data

* Premium members only.

The historical data trend for Techno Medical PCL's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Techno Medical PCL ROCE % Chart

Techno Medical PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.56 4.00 2.12 -1.12 8.69

Techno Medical PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.42 8.96 10.08 7.51 9.19
BKK:TM
74GF Score
Techno Medical PCL BKK:TM
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Techno Medical PCL ROCE % Calculation

Techno Medical PCL's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=47.514/( ( (908.178 - 367.127) + (869.921 - 317.616) )/ 2 )
=47.514/( (541.051+552.305)/ 2 )
=47.514/546.678
=8.69 %

Techno Medical PCL's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=51.192/( ( (869.921 - 317.616) + (916.989 - 354.965) )/ 2 )
=51.192/( ( 552.305 + 562.024 )/ 2 )
=51.192/557.1645
=9.19 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 9.19% mean?
Techno Medical PCL (BKK:TM) has a ROCE % of 9.19% as of Mar. 2026.
Is Techno Medical PCL's ROCE % too high?
Techno Medical PCL's current ROCE % is 9.19%. The Medical Distribution industry median ROCE % is 9.22. Techno Medical PCL's value of 9.19% is 0.3% below this industry median. Overall, Techno Medical PCL has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Techno Medical PCL's ROCE % compare to MCK and COR?
Techno Medical PCL's ROCE % of 9.19% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 9.22. Techno Medical PCL's value of 9.19% is 0.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 9.22, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Techno Medical PCL's current ROCE % of 9.19% is 0.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 9.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Techno Medical PCL's current ROCE % is 9.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Medical PCL stock overvalued right now?
Based on GuruFocus' analysis, Techno Medical PCL (BKK:TM) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.20, compared to a current price of ฿0.94 — trading 21.7% below its estimated fair value. The current ROCE % is 9.19% and 0.3% below the Medical Distribution industry median of 9.22. Techno Medical PCL's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Techno Medical PCL (BKK:TM), the current ROCE % is 9.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Techno Medical PCL (BKK:TM) Overvalued in 2026?

Based on GuruFocus' analysis, Techno Medical PCL stock appears to be undervalued. The current stock price of ฿0.94 is trading 21.7% below its estimated GF Value™ of ฿1.20. GuruFocus considers Techno Medical PCL to be Modestly Undervalued.

Key valuation signals for BKK:TM:

  • ROCE %: 9.19%
  • GF Value™: ฿1.20 vs. price of ฿0.94 (21.7% below fair value)
  • GF Score™: 74/100 with 6 warning signs
  • Industry Position: 0.3% below the Medical Distribution median

No single metric tells the full story. See the BKK:TM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Techno Medical PCL Business Description

Address 29 Soi Latphrao 92, Phlap Phla sub-district, Wang Thong Lang district, Bangkok, THA, 10310
Techno Medical PCL is a Thailand-based company engaged in the trading business of medical supplies, tools, and equipment. The business activity of the group is import and distribution of operating instruments and disposable supplies, central sterile supply department products, instrument and supply used in laboratory and blood bank, and equipment and tools for heart surgery. Its segments consist of Disposable Equipment and Supplies, Sales of Medical Equipment and Instruments and Services related to Nursing Care. Maximum of revenue is Sales of Disposable Equipment and Supplies.
74GF Score

Get the complete analysis for BKK:TM

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿0.94
Price
฿1.20
GF Value